Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Odds Ratio01:09

Odds Ratio

135
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
135
Confidence Intervals01:21

Confidence Intervals

6.2K
An unbiased point estimate is often insufficient to predict a population estimate, such as population mean or population proportion. In this scenario, a confidence interval is used. A confidence interval is an estimate similar to a  sample proportion. However, unlike the point estimate which is a single value, the confidence interval  contains a range of values. These values have lower and upper limits, known as confidence limits, and can be designated as L1 and L2, respectively.
A...
6.2K
Interpretation of Confidence Intervals01:19

Interpretation of Confidence Intervals

5.7K
A confidence interval is a better estimate of the population than a point estimate, as it uses a range of values from a sample instead of a single value.
Confidence intervals have confidence coefficients that are crucial for their interpretation. The most common confidence coefficients are 0.90, 0.95, and 0.99, which can be written as percentages–90%, 95%, and 99%, respectively.
Suppose a person calculates a confidence interval with a confidence coefficient of 0.95. In that case, they can...
5.7K
Hazard Ratio01:12

Hazard Ratio

118
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
118
Confidence Coefficient01:24

Confidence Coefficient

7.6K
The confidence coefficient is also known as the confidence level or degree of confidence. It is the percent expression for the probability, 1-α, that the confidence interval contains the true population parameter assuming that the confidence interval is obtained after sufficient unbiased sampling; for example, if the CL = 90%, then in 90 out of 100 samples the interval estimate will enclose the true population parameter. Here α is the area under the curve, distributed equally under...
7.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alirocumab Plus Cemiplimab in Immunorefractory NSCLC: A Single Arm Phase 2 Study.

Research square·2026
Same author

Prevalence and risk factors of headaches in middle-aged and older Chinese adults with hypertension: a cross-sectional study based on CHARLS.

Scientific reports·2026
Same author

Harnessing multi-omics and machine learning for predicting immune checkpoint blockade responses: Advances, challenges, and future directions.

Fundamental research·2026
Same author

Sex differences in association of cMIND diet with all-cause mortality in Chinese older adults: a 10-year national cohort study.

BMC public health·2026
Same author

Dose-Related Associations Between Physical Activity and Multimorbidity Among Middle-Aged and Older Adults.

Journal of prevention (2022)·2026
Same author

Comprehensive assessment of activity, specificity, and safety of hypercompact TnpB systems for gene editing.

Genome biology·2026

Related Experiment Video

Updated: Jun 29, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

Confidence intervals for odds ratio from multistage randomized phase II trials.

Shiwei Cao1, Sin-Ho Jung1

  • 1Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.

Statistics in Medicine
|April 2, 2024
PubMed
Summary

Multi-stage randomized trials improve efficiency by allowing early stopping. This study introduces exact conditional confidence intervals for odds ratios in phase II trials, ensuring valid statistical inference for these adaptive designs.

Keywords:
futility stoppinggroup sequential designshypergeometric distributionsuperiority stopping

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

261

Related Experiment Videos

Last Updated: Jun 29, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

261

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Medical Research

Background:

  • Multi-stage randomized trial designs offer enhanced efficiency through early termination based on efficacy signals.
  • Standard statistical inference methods can be invalidated by the sequential nature of multi-stage trials.
  • Accurate analysis is crucial for reliable conclusions in adaptive clinical trial designs.

Purpose of the Study:

  • To develop valid statistical inference methods for multi-stage randomized phase II trials.
  • To propose exact conditional confidence intervals for the odds ratio with dichotomous outcomes.
  • To address the invalidity of traditional single-stage confidence intervals in adaptive trial settings.

Main Methods:

  • Focus on multi-stage randomized phase II trials with dichotomous outcomes (e.g., treatment response).
  • Propose exact conditional confidence intervals for the odds ratio.
  • Utilize a linear ordering of outcomes conditioned on the total number of responders per stage and the exact conditional distribution function.

Main Results:

  • Developed a method for valid statistical inference in multi-stage randomized trials.
  • Proposed exact conditional confidence intervals that account for the trial's multi-stage structure.
  • Demonstrated the invalidity of standard single-stage confidence intervals in this context.

Conclusions:

  • The proposed method provides accurate confidence intervals for odds ratios in multi-stage phase II trials.
  • Exact conditional inference is essential for maintaining statistical validity in adaptive trial designs.
  • This approach enhances the reliability of results from efficient, early-terminating clinical trials.